BNT-151

N/A

Report date: 2026/04/07 20:00:20

Base Information

Drug NameBNT-151
Drug Alias NameBNT-151
ClassificationCell and gene therapy > Gene therapy > mRNA
Mechanisms of ActionInterleukin-2 receptor antagonistsImmunostimulantsT lymphocytes stimulants
TargetsInterleukin-2 receptor
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSpain
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBiontech Se
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiontech Se
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A